Latest Biosimilar Stories
Twenty-five pharmaceutical companies being asked to adopt common principles re biosimilars on patient safety, lobbying and business partnerships. DETROIT, Aug.
Step Edits Are the Most Likely Strategy to Drive Use of a Biosimilar Priced 30 Percent Less than the Reference Brand, According to Findings from Decision Resources Group BURLINGTON, Mass.,
MarketOptimizer.org adds “PharmaSphere Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market” to its store.
While Expressing Concerns about Reimbursement, EU5 Payers Look Favorably on Identifying Anti-IL5 Therapy-Responsive Patients, According to Findings from Decision Resources Group BURLINGTON,
The human insulin market is segmented based on types of insulin, and branded drugs available in the market.
New research report “Botulinum Neurotoxins: A Comparative Industry Analysis Of Products, Pipelines, Technologies And Stakeholders” prepared by La Merie Publishing is now available at MarketPublishers.com.
Study quantifies lost savings from REMS and related restricted access tactics WASHINGTON, July 23, 2014 /PRNewswire-iReach/ -- Use of Risk Evaluation and Mitigation Strategies (REMS)
PORTLAND, Oregon, July 21, 2014 /PRNewswire/ -- A new report by Allied Market Research titled, "Global biosimilars/follow-on-biologics market (types, applications and geography)
LONDON, July 21, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Company Advances Development as Part of Collaboration with Baxter International's Biopharmaceutical Business REDWOOD CITY, Calif., July 16, 2014 /PRNewswire/ --
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.